1330128-62-5Relevant articles and documents
Aryltriflates as a neglected moiety in medicinal chemistry: A case study from a lead optimization of CXCL8 inhibitors
Moriconi, Alessio,Bigogno, Chiara,Bianchini, Gianluca,Caligiuri, Antonio,Resconi, Anna,Dondio, Massimo G.,D'Anniballe, Gaetano,Allegretti, Marcello
supporting information; experimental part, p. 768 - 773 (2011/12/02)
Interleukin-8 and growth related oncogene-α-chemokines (formerly CXCL8 and CXCL1, respectively) mediate chemotaxis of neutrophils to inflammatory sites via interactions with two transmembrane receptors, the type A CXCL8 receptor (CXCR1) and the type B CXC